Cardiome Announces Investigational Candidate, Vernakalant, Meets Primary Endpoint in European Comparator Study

http://www.therapeuticsdaily.com/news/article.cfm?contentvalue=1950287&contenttype=sentryarticle&channelID=26

Comments are closed.